Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Tissue transglutaminase in marmoset experimental multiple sclerosis: discrepancy between white and grey matter.

Espitia Pinzon N, Stroo E, 't Hart BA, Bol JG, Drukarch B, Bauer J, van Dam AM.

PLoS One. 2014 Jun 24;9(6):e100574. doi: 10.1371/journal.pone.0100574. eCollection 2014.

2.

Appearance of tissue transglutaminase in astrocytes in multiple sclerosis lesions: a role in cell adhesion and migration?

van Strien ME, Drukarch B, Bol JG, van der Valk P, van Horssen J, Gerritsen WH, Breve JJ, van Dam AM.

Brain Pathol. 2011 Jan;21(1):44-54. doi: 10.1111/j.1750-3639.2010.00428.x. Epub 2010 Aug 20.

PMID:
20731658
3.

The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26.

Kotsakis P, Wang Z, Collighan RJ, Griffin M.

Amino Acids. 2011 Oct;41(4):909-21. doi: 10.1007/s00726-010-0790-1. Epub 2010 Nov 3.

PMID:
21046178
4.

Astrocyte-derived tissue transglutaminase interacts with fibronectin: a role in astrocyte adhesion and migration?

van Strien ME, Brevé JJ, Fratantoni S, Schreurs MW, Bol JG, Jongenelen CA, Drukarch B, van Dam AM.

PLoS One. 2011;6(9):e25037. doi: 10.1371/journal.pone.0025037. Epub 2011 Sep 16.

5.

Interleukin-1β and interleukin-1 receptor antagonist appear in grey matter additionally to white matter lesions during experimental multiple sclerosis.

Prins M, Eriksson C, Wierinckx A, Bol JG, Binnekade R, Tilders FJ, Van Dam AM.

PLoS One. 2013 Dec 23;8(12):e83835. doi: 10.1371/journal.pone.0083835. eCollection 2013.

6.

Pathological differences between white and grey matter multiple sclerosis lesions.

Prins M, Schul E, Geurts J, van der Valk P, Drukarch B, van Dam AM.

Ann N Y Acad Sci. 2015 Sep;1351:99-113. doi: 10.1111/nyas.12841. Epub 2015 Jul 22. Review.

PMID:
26200258
7.

Exploring the origins of grey matter damage in multiple sclerosis.

Calabrese M, Magliozzi R, Ciccarelli O, Geurts JJ, Reynolds R, Martin R.

Nat Rev Neurosci. 2015 Mar;16(3):147-58. doi: 10.1038/nrn3900. Review.

PMID:
25697158
8.

RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 α5β1 integrin co-signaling.

Wang Z, Collighan RJ, Gross SR, Danen EH, Orend G, Telci D, Griffin M.

J Biol Chem. 2010 Dec 17;285(51):40212-29. doi: 10.1074/jbc.M110.123703. Epub 2010 Oct 7.

9.

Differential macrophage/microglia activation in neocortical EAE lesions in the marmoset monkey.

Merkler D, Böscke R, Schmelting B, Czéh B, Fuchs E, Brück W, Stadelmann C.

Brain Pathol. 2006 Apr;16(2):117-23.

PMID:
16768751
10.

Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients.

Prins M, Dutta R, Baselmans B, Brevé JJ, Bol JG, Deckard SA, van der Valk P, Amor S, Trapp BD, de Vries HE, Drukarch B, van Dam AM.

Acta Neuropathol Commun. 2014 Aug 23;2:98. doi: 10.1186/s40478-014-0098-6.

11.

Increased microglial catalase activity in multiple sclerosis grey matter.

Gray E, Kemp K, Hares K, Redondo J, Rice C, Scolding N, Wilkins A.

Brain Res. 2014 Apr 22;1559:55-64. doi: 10.1016/j.brainres.2014.02.042. Epub 2014 Mar 3.

PMID:
24602691
12.

Enhanced osteoblast adhesion on transglutaminase 2-crosslinked fibronectin.

Forsprecher J, Wang Z, Nelea V, Kaartinen MT.

Amino Acids. 2009 Apr;36(4):747-53. doi: 10.1007/s00726-008-0125-7. Epub 2008 Jul 5.

PMID:
18604470
13.

Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin.

Akimov SS, Krylov D, Fleischman LF, Belkin AM.

J Cell Biol. 2000 Feb 21;148(4):825-38.

14.

Transglutaminase 2 and neuroinflammation.

Ientile R, Currò M, Caccamo D.

Amino Acids. 2015 Jan;47(1):19-26. doi: 10.1007/s00726-014-1864-2. Epub 2014 Nov 15. Review.

PMID:
25398223
15.

Transglutaminase 2 exacerbates experimental autoimmune encephalomyelitis through positive regulation of encephalitogenic T cell differentiation and inflammation.

Oh K, Park HB, Seo MW, Byoun OJ, Lee DS.

Clin Immunol. 2012 Nov;145(2):122-32. doi: 10.1016/j.clim.2012.08.009. Epub 2012 Aug 23.

PMID:
23001131
16.

Up-regulation of fibronectin and tissue transglutaminase promotes cell invasion involving increased association with integrin and MMP expression in A431 cells.

Chen SH, Lin CY, Lee LT, Chang GD, Lee PP, Hung CC, Kao WT, Tsai PH, Schally AV, Hwang JJ, Lee MT.

Anticancer Res. 2010 Oct;30(10):4177-86.

PMID:
21036738
17.

Transglutaminase-2 interaction with heparin: identification of a heparin binding site that regulates cell adhesion to fibronectin-transglutaminase-2 matrix.

Lortat-Jacob H, Burhan I, Scarpellini A, Thomas A, Imberty A, Vivès RR, Johnson T, Gutierrez A, Verderio EA.

J Biol Chem. 2012 May 25;287(22):18005-17. doi: 10.1074/jbc.M111.337089. Epub 2012 Mar 22.

18.

A novel extracellular role for tissue transglutaminase in matrix-bound VEGF-mediated angiogenesis.

Wang Z, Perez M, Caja S, Melino G, Johnson TS, Lindfors K, Griffin M.

Cell Death Dis. 2013 Sep 19;4:e808. doi: 10.1038/cddis.2013.318.

20.

A crucial sequence for transglutaminase type 2 extracellular trafficking in renal tubular epithelial cells lies in its N-terminal beta-sandwich domain.

Chou CY, Streets AJ, Watson PF, Huang L, Verderio EA, Johnson TS.

J Biol Chem. 2011 Aug 5;286(31):27825-35. doi: 10.1074/jbc.M111.226340. Epub 2011 Jun 7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk